| Literature DB >> 33664732 |
Yang Li1, Gen Li1, Jian Zhang1, Xiaoli Wu2, Xi Chen3.
Abstract
γδ T cells are the unique T cell subgroup with their T cell receptors composed of γ chain and δ chain. Unlike αβ T cells, γδ T cells are non-MHC-restricted in recognizing tumor antigens, and therefore defined as innate immune cells. Activated γδ T cells can promote the anti-tumor function of adaptive immune cells. They are considered as a bridge between adaptive immunity and innate immunity. However, several other studies have shown that γδ T cells can also promote tumor progression by inhibiting anti-tumor response. Therefore, γδ T cells may have both anti-tumor and tumor-promoting effects. In order to clarify this contradiction, in this review, we summarized the functions of the main subsets of human γδ T cells in how they exhibit their respective anti-tumor or pro-tumor effects in cancer. Then, we reviewed recent γδ T cell-based anti-tumor immunotherapy. Finally, we summarized the existing problems and prospect of this immunotherapy.Entities:
Keywords: human; immunity; immunotherapy; tumor; γδ T cells
Mesh:
Substances:
Year: 2021 PMID: 33664732 PMCID: PMC7921733 DOI: 10.3389/fimmu.2020.619954
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561